Funabashi, Japan

Kazuhiro Kagami




Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kazuhiro Kagami: Innovator in Pharmaceutical Treatments

Introduction

Kazuhiro Kagami is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory and infectious diseases. With a total of four patents to his name, Kagami's work is characterized by innovative approaches to drug formulation.

Latest Patents

Kagami's latest patents include a method of treating an inflammatory or infectious disease. This method involves administering an effective amount of a pharmaceutical composition that contains an aqueous suspension of nanoparticles of a glucocorticosteroid compound. Another significant patent is for an aqueous suspension preparation that comprises a macrolide antibacterial agent as an active component. This preparation is notable for its nanoparticles, which have an average particle size of 500 nm or less, and it is designed for various applications, including eye drops and ear drops for treating inflammatory diseases.

Career Highlights

Kagami is currently associated with Activus Pharma Co., Ltd., where he continues to develop innovative pharmaceutical solutions. His work has been instrumental in advancing treatment options for patients suffering from various inflammatory conditions.

Collaborations

Kagami collaborates with talented individuals such as Takahiro Tada and Kenta Kikuchi, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kazuhiro Kagami's contributions to pharmaceutical inventions highlight his commitment to improving healthcare through innovative treatments. His patents reflect a deep understanding of drug formulation and a dedication to addressing pressing medical needs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…